Partial Loss of the Glutamate Transporter GLT-1 Alters Brain Akt and Insulin Signaling in a Mouse Model of Alzheimer's Disease

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2015-03-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3233/JAD-142304PMID 25589729PMCID PMC4920068
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brain metabolic dysfunction at the core of Alzheimer's disease.

  2014cited by this paper
• Neuronal Activity and Glutamate Uptake Decrease Mitochondrial Mobility in Astrocytes and Position Mitochondria Near Glutamate Transporters

  2014cited by this paper
• Proteome Analysis and Conditional Deletion of the EAAT2 Glutamate Transporter Provide Evidence against a Role of EAAT2 in Pancreatic Insulin Secretion in Mice*

  2013cited by this paper
• Amyloid-β1–42 Slows Clearance of Synaptically Released Glutamate by Mislocalizing Astrocytic GLT-1

  2013cited by this paper
• Insulin, cognition, and dementia.

  2013cited by this paper
• Differential Expression of the Glutamate Transporter GLT-1 in Pancreas

  2012cited by this paper
• Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.

  2012cited by this paper
• Parasynaptic NMDA Receptor Signaling Couples Neuronal Glutamate Transporter Function to AMPA Receptor Synaptic Distribution and Stability

  2012influential reference
• Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks.

  2012cited by this paper
• Insulin increases glutamate transporter GLT1 in cultured astrocytes.

  2011cited by this paper
• Deletion of Insulin-Degrading Enzyme Elicits Antipodal, Age-Dependent Effects on Glucose and Insulin Tolerance

  2011cited by this paper
• GLT-1 Loss Accelerates Cognitive Deficit Onset in an Alzheimer's Disease Animal Model

  2011influential reference
• Aberrant Detergent-Insoluble Excitatory Amino Acid Transporter 2 Accumulates in Alzheimer Disease

  2010cited by this paper
• PI3K/Akt/mTOR signaling regulates glutamate transporter 1 in astrocytes.

  2010cited by this paper
• Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling.

  2010cited by this paper
• Peripheral Amyloid-β Levels Regulate Amyloid-β Clearance from the Central Nervous System

  2009influential reference
• Phosphorylation of IRS proteins, insulin action, and insulin resistance.

  2009cited by this paper
• Cognitive Decline in Alzheimer's Disease Is Associated with Selective Changes in Calcineurin/NFAT Signaling

  2009cited by this paper
• Development of potent, allosteric dual Akt1 and Akt2 inhibitors with improved physical properties and cell activity.

  2008cited by this paper
• Abeta-degrading enzymes in Alzheimer's disease.

  2008cited by this paper
• Glutamate Uptake is Reduced in Prefrontal Cortex in Huntington’s Disease

  2008cited by this paper
• The blood-brain barrier in health and chronic neurodegenerative disorders.

  2008cited by this paper
• Active and passive immunotherapy for neurodegenerative disorders.

  2008cited by this paper
• Amyloid beta oligomers induce impairment of neuronal insulin receptors

  2008cited by this paper
• Extracellular Glutamate Concentration in Hippocampal Slice

  2007cited by this paper
• Alterations in Expression of Glutamatergic Transporters and Receptors in Sporadic Alzheimer's Disease

  2007cited by this paper
• Insulin degrading enzyme activity selectively decreases in the hippocampal formation of cases at high risk to develop Alzheimer's disease.

  2007cited by this paper
• Regulation of astrocytic glutamate transporter expression by Akt: evidence for a selective transcriptional effect on the GLT‐1/EAAT2 subtype

  2006cited by this paper
• Critical nodes in signalling pathways: insights into insulin action

  2006cited by this paper
• Decreased Expression of Glutamate Transporters in Astrocytes after Human Traumatic Brain Injury

  2006cited by this paper
• Pathophysiology of insulin resistance.

  2006cited by this paper
• Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse

  2006cited by this paper
• Distribution of the glutamate transporters GLT-1 (SLC1A2) and GLAST (SLC1A3) in peripheral organs

  2006cited by this paper
• Major Involvement of Low-Density Lipoprotein Receptor-Related Protein 1 in the Clearance of Plasma Free Amyloid β-Peptide by the Liver

  2006cited by this paper
• Another role for the celebrity: Akt and insulin resistance.

  2005cited by this paper
• Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology

  2005cited by this paper
• Akt Mediates the Cross-Talk Between &bgr;-Adrenergic and Insulin Receptors in Neonatal Cardiomyocytes

  2005cited by this paper
• Decreased metabolic response to visual stimulation in the superior colliculus of mice lacking the glial glutamate transporter GLT‐1

  2005cited by this paper
• Clearance of Alzheimer's Abeta peptide: the many roads to perdition.

  2004cited by this paper
• Climbing Fiber Activation of EAAT4 Transporters and Kainate Receptors in Cerebellar Purkinje Cells

  2004cited by this paper
• Clearance of Alzheimer's Aβ Peptide

  2004cited by this paper
• Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase.

  2004cited by this paper
• Glutamate uptake determines pathway specificity of long-term potentiation in the neural circuitry of fear conditioning.

  2004cited by this paper
• Akt activity in Alzheimer's disease and other neurodegenerative disorders

  2004cited by this paper
• Diet‐induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease

  2004influential reference
• Systemic catabolism of Alzheimer's Abeta40 and Abeta42.

  2004cited by this paper
• Altered expression of the glutamate transporter EAAT2b in neurological disease

  2004cited by this paper
• Clearing amyloid through the blood–brain barrier

  2004cited by this paper
• Systemic Catabolism of Alzheimer's Aβ40 and Aβ42*

  2004cited by this paper
• Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase

  2004cited by this paper
• Statistical Principles in Experimental Design

  2003cited by this paper
• Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo

  2003influential reference
• Role of protein kinase B in Alzheimer's neurofibrillary pathology

  2003cited by this paper
• Apolipoprotein E influences amyloid-beta clearance from the murine periphery

  2003cited by this paper
• Glial glutamate transporters mediate a functional metabolic crosstalk between neurons and astrocytes in the mouse developing cortex.

  2003cited by this paper
• Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele.

  2003influential reference
• Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.

  2003cited by this paper
• Reduced Hippocampal Insulin-Degrading Enzyme in Late-Onset Alzheimer's Disease Is Associated with the Apolipoprotein E-ε4 Allele

  2003cited by this paper
• Appraising the brain's energy budget

  2002cited by this paper
• New targets of β-catenin signaling in the liver are involved in the glutamine metabolism

  2002cited by this paper
• Glutamate uptake.

  2001cited by this paper
• A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1

  2001influential reference
• Discovering Statistics Using SPSS

  2000cited by this paper
• Synaptically released glutamate does not overwhelm transporters on hippocampal astrocytes during high-frequency stimulation.

  2000cited by this paper
• Insulysin Hydrolyzes Amyloid β Peptides to Products That Are Neither Neurotoxic Nor Deposit on Amyloid Plaques

  2000cited by this paper
• Degradation of Amylin by Insulin-degrading Enzyme*

  2000cited by this paper
• Motor discoordination and increased susceptibility to cerebellar injury in GLAST mutant mice

  1998cited by this paper
• Insulin degradation: progress and potential.

  1998cited by this paper
• The Number of Glutamate Transporter Subtype Molecules at Glutamatergic Synapses: Chemical and Stereological Quantification in Young Adult Rat Brain

  1998cited by this paper
• RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1.

  1998cited by this paper
• Glutamate transporter EAAC‐1‐deficient mice develop dicarboxylic aminoaciduria and behavioral abnormalities but no neurodegeneration

  1997cited by this paper
• Changes of NMDA Receptor Subunit (NR1, NR2B) and Glutamate Transporter (GLT1) mRNA Expression in Huntington's Disease—An In Situ Hybridization Study

  1997cited by this paper
• Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1.

  1997influential reference
• Transporters Buffer Synaptically Released Glutamate on a Submillisecond Time Scale

  1997cited by this paper
• Deficient glutamate tranport is associated with neurodegeneration in Alzheimer's disease

  1996influential reference
• IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance

  1996cited by this paper
• Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease.

  1996cited by this paper
• Brain Glutamate Transporter Proteins Form Homomultimers*

  1996cited by this paper
• [Pathophysiology of insulin resistance].

  1995cited by this paper
• Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis

  1995cited by this paper
• Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis.

  1992cited by this paper

• Unscrambling the cellular and molecular threads of Neuroplasticity: Insights into Alzheimer's disease pathogenesis.

  2025cites this paper
• Glutamate Transporter 1 as a Novel Negative Regulator of Amyloid β

  2024cites this paper
• Impacts of glutamate, an exercise-responsive metabolite on insulin signaling.

  2024cites this paper
• Bioactive human Alzheimer brain soluble Aβ: pathophysiology and therapeutic opportunities

  2022cites this paper
• Control of complex behavior by astrocytes and microglia.

  2022cites this paper
• Single-Cell Transcriptional Profiling and Gene Regulatory Network Modeling in Tg2576 Mice Reveal Gender-Dependent Molecular Features Preceding Alzheimer-Like Pathologies

  2022cites this paper
• Activation of the TREK-1 Potassium Channel Improved Cognitive Deficits in a Mouse Model of Alzheimer’s Disease by Modulating Glutamate Metabolism

  2022cites this paper
• Evaluation of Utilizing the Distinct Genes as Predictive Biomarkers in Late-Onset Alzheimer's Disease

  2022cites this paper
• Amyloid‐β plaques affect astrocyte Kir4.1 protein expression but not function in the dentate gyrus of APP/PS1 mice

  2022cites this paper
• Estimating the glutamate transporter surface density in distinct sub-cellular compartments of mouse hippocampal astrocytes

  2022cites this paper
• Activation of TREK-1 Potassium Channel Improved Cognitive Deficits in Alzheimer's Disease Model Mice by Modulation of Glutamate Metabolic Pathway

  2021cites this paper
• Reactive astrocytes: The nexus of pathological and clinical hallmarks of Alzheimer’s disease

  2021cites this paper
• Epileptic Mechanisms Shared by Alzheimer’s Disease: Viewed via the Unique Lens of Genetic Epilepsy

  2021cites this paper
• Estimating the glutamate transporter surface density in distinct sub-cellular compartments of mouse hippocampal astrocytes

  2021cites this paper
• Positive allosteric activation of glial EAAT-2 transporter protein: A novel strategy for Alzheimer's disease.

  2020cites this paper
• Amyloid‐β oligomers in cellular models of Alzheimer’s disease

  2020cites this paper
• The Dual Role of Glutamatergic Neurotransmission in Alzheimer’s Disease: From Pathophysiology to Pharmacotherapy

  2020cites this paper
• Potential Astrocytic Receptors and Transporters in the Pathogenesis of Alzheimer’s Disease

  2019cites this paper
• Agathisflavone, a flavonoid derived from Poincianella pyramidalis (Tul.), enhances neuronal population and protects against glutamate excitotoxicity

  2018cites this paper
• Astrocytic glutamatergic transporters are involved in Aβ-induced synaptic dysfunction.

  2018cites this paper
• Generation of Defined Astrocytic Phenotypesfrom Human Pluripotent Stem Cellsfor Transplantation after Spinal Cord Injury

  2017cites this paper
• Calcineurin/NFAT Signaling in Activated Astrocytes Drives Network Hyperexcitability in Aβ-Bearing Mice

  2017cites this paper
• Mechanism of 2,3,4',5-Tetrahydroxystilbene 2-O-β-D-Glucoside-Induced Upregulation of Glutamate Transporter 1 Protein Expression in Mouse Primary Astrocytes

  2017cites this paper
• Astrocyte transport of glutamate and neuronal activity reciprocally modulate tau pathology in Drosophila.

  2017cites this paper
• Targeting Nanoparticles to Brain: Impact of N-Methyl d -Aspartate Receptors

  2017cites this paper
• Identification of proteins that are differentially expressed in brains with Alzheimer's disease using iTRAQ labeling and tandem mass spectrometry.

  2016cites this paper
• Glutamate transporters: The arrestin connection

  2016cites this paper
• Brain local and regional neuroglial alterations in Alzheimer's Disease: cell types, responses and implications.

  2016cites this paper
• Astrogliosis: An integral player in the pathogenesis of Alzheimer's disease.

  2016cites this paper
• The neuroprotective mechanism of ampicillin in a mouse model of transient forebrain ischemia

  2016cites this paper
• Current approaches to enhance glutamate transporter function and expression

  2015cites this paper